Search - tctmd.com

Displaying 681 - 700 of 1074

Sort: Relevancy | Date

News Features

Asymptomatic Aortic Stenosis: The Next Frontier for TAVR?

L.A. McKeown

April 18, 2016

News Daily News

A-fib Post-TAVR Associated With Increased Risk of Mortality, Bleeding

Michael O'Riordan

April 18, 2016

News Conference News ACC 2016

CABG Beats Medical Therapy in CAD Patients With Severe LV Dysfunction: STICH 10-Year Results

Shelley Wood

April 08, 2016

News Conference News ACC 2016

Valve Hemodynamic Deterioration Post-TAVR Is Rare, Not Linked With Adverse Cardiovascular Outcomes

Michael O'Riordan

April 07, 2016

News Industry News

St. Jude Medical Announces the European Launch of the Trifecta Surgical Valve with Glide Technology to Improve Options for Patients in Need of Aortic Valve Replacement

April 07, 2016

News Conference News ACC 2016

Choosing Radial Over Femoral: Single-Center Study Tackles Questions of When and Why

Yael L. Maxwell

April 06, 2016

News Industry News

LivaNova PLC Announces the First Patient Enrolled in the PERSIST-AVR Trial

April 04, 2016

News Conference News ACC 2016

TAVR Mortality Declines as Volumes Increase: So How Many US Centers Are Enough?

Shelley Wood

April 03, 2016

News Daily News

Minimally Invasive Mitral Valve Surgery Gives Good Outcomes Without Increasing Costs

Todd Neale

April 01, 2016

News Industry News

First Patients Enrolled in Medtronic Trial in Low-Risk Aortic Stenosis Patients

April 01, 2016

News Features

Where Theory Meets Practice: Getting to the Heart of the Heart Team

Yael L. Maxwell

March 30, 2016

News Opinion Editor's Corner

ACC 2016: HOPE for Primary Prevention, TAVR in Moderate-Risk Patients, Deferred Stenting in STEMI, and More

Shelley Wood

March 28, 2016

News Industry News

Edwards Lifesciences Receives Approval For SAPIEN 3 Valve In Japan

March 16, 2016

News Daily News

Risk Model Improves Practical Prediction of In-Hospital Mortality After TAVR

L.A. McKeown

March 08, 2016

News Industry News

LivaNova, PLC Announces the First U.S. Implants of Perceval, the Only Sutureless Valve for Aortic Valve Replacement Surgery

March 08, 2016

News Industry News

BioStable Science & Engineering Announces CE Mark Approval for the HAART 300 Aortic Annuloplasty Device

March 07, 2016

News Daily News

新的分析未能证实 CTO PCI 成功和死亡率降低之间存在关联

Todd Neale

March 06, 2016

News Daily News

New Analysis Fails to Find Link Between Successful CTO PCI and Lower Mortality

Todd Neale

March 06, 2016

News Industry News

Medtronic Enrolls First Patients in Clinical Study to Evaluate the CoreValve(TM) Evolut(TM) R System in 'Real-World' Setting

March 06, 2016

News Industry News

Edwards SAPIEN XT Valve Receives FDA Approval For Pulmonic Procedures

March 01, 2016

Advertisement

Asymptomatic Aortic Stenosis: The Next Frontier for TAVR?

A-fib Post-TAVR Associated With Increased Risk of Mortality, Bleeding

CABG Beats Medical Therapy in CAD Patients With Severe LV Dysfunction: STICH 10-Year Results

Valve Hemodynamic Deterioration Post-TAVR Is Rare, Not Linked With Adverse Cardiovascular Outcomes

St. Jude Medical Announces the European Launch of the Trifecta Surgical Valve with Glide Technology to Improve Options for Patients in Need of Aortic Valve Replacement

Choosing Radial Over Femoral: Single-Center Study Tackles Questions of When and Why

LivaNova PLC Announces the First Patient Enrolled in the PERSIST-AVR Trial

TAVR Mortality Declines as Volumes Increase: So How Many US Centers Are Enough?

Minimally Invasive Mitral Valve Surgery Gives Good Outcomes Without Increasing Costs

First Patients Enrolled in Medtronic Trial in Low-Risk Aortic Stenosis Patients

Where Theory Meets Practice: Getting to the Heart of the Heart Team

ACC 2016: HOPE for Primary Prevention, TAVR in Moderate-Risk Patients, Deferred Stenting in STEMI, and More

Edwards Lifesciences Receives Approval For SAPIEN 3 Valve In Japan

Risk Model Improves Practical Prediction of In-Hospital Mortality After TAVR

LivaNova, PLC Announces the First U.S. Implants of Perceval, the Only Sutureless Valve for Aortic Valve Replacement Surgery

BioStable Science & Engineering Announces CE Mark Approval for the HAART 300 Aortic Annuloplasty Device

新的分析未能证实 CTO PCI 成功和死亡率降低之间存在关联

New Analysis Fails to Find Link Between Successful CTO PCI and Lower Mortality

Medtronic Enrolls First Patients in Clinical Study to Evaluate the CoreValve(TM) Evolut(TM) R System in 'Real-World' Setting

Edwards SAPIEN XT Valve Receives FDA Approval For Pulmonic Procedures

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content